Dr. Yue M. Wang, MD

Dr. Wang practices at Florida Eye Associates Inc in Melbourne, Florida.

Dr. Wang's NPI, 1851598403, was assigned on June 28, 2007. Dr. Wang graduated from Vanderbilt University School Of Medicine in 2004. Dr. Wang holds Florida license ME107258.

Dr. Wang's primary practice is Florida Eye Associates Inc, at 502 E New Haven Ave, Melbourne, FL 32901 in Brevard County. The practice phone is (321) 727-2020.

Dr. Wang's primary practice is Florida Eye Associates Inc in Melbourne, Florida. Dmand AI also links Dr. Wang to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Wang is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Wang's licenses on file in 4 states: Florida, Maryland, North Carolina and Connecticut.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Wang treats.

CMS data shows 3,215 Medicare services from Dr. Wang across 17 procedure codes in 2024, for 846 Medicare patients. Medicare paid $199,591 for them.

CMS counts 846 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 349 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 76, with 60% women.

In 2024, Dr. Wang wrote 6,063 Medicare Part D claims for 1,023 patients. 73% of them were for generic drugs. CMS names the drug for 5,988 of them, across 27 drugs with 11 or more claims each, at $461,337 in total drug cost. In 2023, CMS named 5,448 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of cataract surgery by Dr. Wang, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Wang, published from 2009 to 2016. The most frequent topics are Visual Acuity. Dr. Wang's most frequent co-authors are Sari A. Acra, MD, Daniel Moore, MD and David Brent Polk, MD.

CMS Open Payments shows 42 general payments to Dr. Wang from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Celgene Corporation paid the most, $282.

Dr. Wang graduated from Vanderbilt University School Of Medicine in 2004.

Dr. Wang is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.